Morning Briefing
Summaries of health policy coverage from major news organizations
J&J Fined $1.2B For Hiding Anti-Psychotic Drug Dangers, Deceptive Marketing
An Arkansas judge fined the drug maker and a subsidiary for misleading doctors and the public on the risks involved with taking an anti-psychotic drug, Risperdal, and for marketing the drug for an off-label use to the state's Medicaid system.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
